Baker Biotech Capital III (GP), LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Biotech Capital III (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital III (GP), LLC. Baker Biotech Capital III (GP), LLC is a 10% Owner in VIROPHARMA INC ($VPHM) and a 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and a Director in SEATTLE GENETICS INC /WA ($SGEN).
Address: 667 MADISON AVENUE NEW YORK 10021 NY
Companies in which Baker Biotech Capital III (GP), LLC is an Insider
Ardea Biosciences, Inc./DE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital III (GP), LLC: 10% Owner
Holdings: 1,256 shares
Latest Transaction: Apr 14 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Biotech Capital III (GP), LLC: Director
Holdings: 234,861 shares
Current Value: $14,277,200
Latest Transaction: May 06 2005
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VIROPHARMA INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital III (GP), LLC: 10% Owner
Holdings: 1,648,599 shares
Latest Transaction: Mar 01 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Baker Biotech Capital III (GP), LLC
Sentiment: All, IBPI, SGEN, VPHM
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Sell | S | 20.41 | 32,063 | 654,435 | 1,648,599 | 1.7 M to 1.6 M (-1.91 %) |
| Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Sell | S | 19.90 | 65,192 | 1,297,014 | 1,680,662 | 1.7 M to 1.7 M (-3.73 %) |
| Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Sell | S | 21.81 | 184 | 4,012 | 1,745,854 | 1.7 M to 1.7 M (-0.01 %) |
| Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Sell | S | 21.58 | 9,963 | 215,001 | 1,746,038 | 1.8 M to 1.7 M (-0.57 %) |
| Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Sell | S | 21.72 | 44,449 | 965,619 | 1,756,001 | 1.8 M to 1.8 M (-2.47 %) |
| Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Sell | S | 21.74 | 43,922 | 954,996 | 1,800,450 | 1.8 M to 1.8 M (-2.38 %) |
| May 12 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital III (GP) ... | 10% Owner | Option Exercise | P | 2.50 | 123,000 | 307,500 | 4,314,000 |
View all Baker Biotech Capital III (GP), LLC insider transactions.